跳转至内容
Merck
CN
所有图片(1)

文件

安全信息

59357-U40

Supelco

Discovery® Cyano (5 µm) HPLC Columns

L × I.D. 25 cm × 4 mm, HPLC Column

登录查看公司和协议定价

UNSPSC代码:
41115700
eCl@ss:
32110501
NACRES:
SB.52

product name

Cyano HPLC 色谱柱 ®, 5 μm particle size, L × I.D. 25 cm × 4 mm

物料

stainless steel column

质量水平

Agency

suitable for USP L10

产品线

Discovery®

特点

endcapped

制造商/商品名称

Discovery®

包装

1 ea of

标记范围

4.5% Carbon loading

参数

≤70 °C temp. range
400 bar pressure (5801 psi)

技术

HPLC: suitable
LC/MS: suitable

长度 × 内径

25 cm × 4 mm

表面积

200 m2/g

表面覆盖度

3.5 μmol/m2

杂质

<10 ppm metals

基质

silica gel, high purity, spherical base material
fully porous particle

基质活性基团

cyano phase

粒径

5 μm

孔径

180 Å

operating pH range

2-8

应用

food and beverages

分离技术

hydrophilic interaction (HILIC)
normal phase
reversed phase

正在寻找类似产品? 访问 产品对比指南

相关类别

特点和优势

  • 低疏水性可实现对疏水性化合物的快速洗脱
  • 分析强碱性化合物具有优良的峰形和保留性能
  • 对极性化合物具有较强的保留能力
  • 独特的选择性
  • 保留时间显著小于 C18 柱(通常流动相中所需有机相比例更低)
  • 稳定性好、低流失,适用于 LC-MS 分析
  • 与高含水量的流动相兼容

法律信息

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Graciela B Arhancet et al.
Journal of medicinal chemistry, 53(16), 5970-5978 (2010-08-03)
A new 1,4-dihydropyridine 5a, containing a cyano group at the C3 position, was recently reported to possess excellent mineralocorticoid receptor (MR) antagonist in vitro potency and no calcium channel-blocker (CCB) activity. In the present study, we report the structure-activity relationships
K Umekawa et al.
Japanese journal of pharmacology, 84(1), 7-15 (2000-10-24)
We describe the pharmacological characteristics of SM-19712 (4-chloro-N-[[(4-cyano-3-methyl-1-phenyl-1H-pyrazol-5-yl)amino]carbonyl] benzenesulfonamide, monosodium salt). SM-19712 inhibited endothelin converting enzyme (ECE) solubilized from rat lung microsomes with an IC50 value of 42 nM and, at 10 - 100 microM, had no effect on other
Srdan Verstovsek et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 14(3), 788-796 (2008-02-05)
The discovery of an activating somatic mutation in codon 617 of the gene encoding the Janus kinase (JAK)-2 (JAK2 V617F) in patients with myeloproliferative disorders has opened new avenues for the development of targeted therapies for these malignancies. However, no
Christophe Morisseau et al.
Analytical biochemistry, 414(1), 154-162 (2011-03-05)
The microsomal epoxide hydrolase (mEH) plays a significant role in the metabolism of numerous xenobiotics. In addition, it has a potential role in sexual development and bile acid transport, and it is associated with a number of diseases such as
Arnout Voet et al.
ChemMedChem, 8(4), 644-651 (2013-02-26)
Unraveling the mechanisms involved in castration- and therapy-resistant prostate cancer has led to a renewed interest in androgen receptor (AR)-targeted therapeutics. Anti-androgens that block the activity of the AR therefore remain a valid therapeutic option. However, they must be more

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门